Combined Pharmacophore Modeling, 3D-QSAR, Homology Modeling and Docking Studies on CYP11B1 Inhibitors

Combined Pharmacophore Modeling, 3D-QSAR, Homology Modeling and Docking Studies on CYP11B1 Inhibitors

The mitochondrial cytochrome P450 enzymes inhibitor steroid 11β-hydroxylase (CYP11B1) can decrease the production of cortisol. Therefore, these inhibitors have an effect in the treatment of Cushing’s syndrome. A pharmacophore model generated by Genetic Algorithm with Linear Assignment for Hypermolec...

Full description

Bibliographic Details
Main Authors:	Rui Yu, Juan Wang, Rui Wang, Yong Lin, Yong Hu, Yuanqiang Wang, Mao Shu, Zhihua Lin
Format:	Article
Language:	English
Published:	MDPI AG 2015-01-01
Series:	Molecules
Subjects:	CYP11B1 inhibitors 3D-QSAR pharmacophore model Cushing’s syndrome
Online Access:	http://www.mdpi.com/1420-3049/20/1/1014

Similar Items

Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
by: Tao Lu, et al.
Published: (2011-12-01)

Predictive Modeling of Antioxidant Coumarin Derivatives Using Multiple Approaches: Descriptor-Based QSAR, 3D-Pharmacophore Mapping, and HQSAR
by: Indrani MITRA, et al.
Published: (2016-09-01)

Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
by: Ji-Xia Ren, et al.
Published: (2020-03-01)

Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
by: Nathalie Moussa, et al.
Published: (2021-04-01)

Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studies
by: Vijay K. Patel, et al.
Published: (2017-12-01)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
by: Michael Kirstgen, et al.
Published: (2021-07-01)

LIGAND BASED PHARMACOPHORE MODELING AND QSAR ANALYSIS OF HETEROCYCLIC DIAMIDINE DERIVATIVES AS ANTI-PARASITIC DNA MINOR GROOVE BINDERS
by: Subhadip Banerjee, et al.
Published: (2013-12-01)

3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists
by: Antonijević Mirjana, et al.
Published: (2017-01-01)

Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer’s Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches
by: Oluwafemi Adeleke Ojo, et al.
Published: (2021-04-01)

Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity
by: Magdi E. A. Zaki, et al.
Published: (2021-08-01)

Combined Structure-Based Pharmacophore and 3D-QSAR Studies on Phenylalanine Series Compounds as TPH1 Inhibitors
by: Mingli Xiang, et al.
Published: (2012-05-01)

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
by: Yongze Yuan, et al.
Published: (2017-04-01)

QPHAR: quantitative pharmacophore activity relationship: method and validation
by: Stefan M. Kohlbacher, et al.
Published: (2021-08-01)

Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors
by: Nannan Zhou, et al.
Published: (2015-06-01)

A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors
by: Huiding Xie, et al.
Published: (2015-05-01)

Hypouricemic effect of Grifola frondosa on hyperuricemic mice and virtual screening of bioactives by 3D QSAR pharmacophore modeling
by: Tianqiao Yong, et al.
Published: (2018-01-01)

Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
by: Qidong You, et al.
Published: (2012-05-01)

Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking
by: Yoon Hyeok Lee, et al.
Published: (2018-10-01)

QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human <i>N</i>-Myristoyltransferase (Hs-NMT) Inhibitors
by: Magdi E. A. Zaki, et al.
Published: (2021-03-01)

3D QSAR Studies, Pharmacophore Modeling and Virtual Screening on a Series of Steroidal Aromatase Inhibitors
by: Huiding Xie, et al.
Published: (2014-11-01)

3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists
by: Radan Milica, et al.
Published: (2017-01-01)

Pharmacophore modeling and 3D quantitative structure-activity relationship analysis of febrifugine analogues as potent antimalarial agent
by: Debanjan Sen, et al.
Published: (2013-01-01)

Novel indole derivatives as hepatitis C virus NS5B polymerase inhibitors: Pharmacophore modeling and 3D QSAR studies
by: G. Varun, et al.
Published: (2014-07-01)

A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report
by: Xianxian Yuan, et al.
Published: (2018-09-01)

Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na+/bile acid cotransporter
by: Karl-Heinz Baringhaus, et al.
Published: (1999-12-01)

Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors
by: Muhammad Akram, et al.
Published: (2017-12-01)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01)

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
by: Serena Nembri, et al.
Published: (2016-06-01)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
by: Alina Kutlushina, et al.
Published: (2018-11-01)

Molecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agents
by: Jovanović Milan, et al.
Published: (2018-01-01)

Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of mGluR2 Antagonists
by: Chun-Zhi Ai, et al.
Published: (2011-09-01)

Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies
by: Maryam Foroozesh, et al.
Published: (2012-08-01)

3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking
by: Wenjuan Yang, et al.
Published: (2012-02-01)

A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report
by: Lian Duan, et al.
Published: (2018-04-01)

Computational Modelling of Structures and Ligands of CYP2C9
by: Afzelius, Lovisa
Published: (2004)

Desenvolvimento de modelos de QSAR para identificação de substratos e inibidores de CYP3A4
by: Silva, Flávia Cristina da
Published: (2016)

Enhanced Biodegradation/Photodegradation of Organophosphorus Fire Retardant Using an Integrated Method of Modified Pharmacophore Model with Molecular Dynamics and Polarizable Continuum Model
by: Jiawen Yang, et al.
Published: (2020-07-01)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01)

Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach
by: Minh-Tri Le, et al.
Published: (2021-05-01)

A Selective Pharmacophore Model for β2-Adrenoceptor Agonists
by: Mao-Sheng Cheng, et al.
Published: (2009-11-01)